Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT01178268
Brief Summary:
This is a prospective, randomized, active-controlled, open label, parallel two-arm, multi-center, post-approval study descriptively comparing the XIENCE V EECSS to the CYPHER SELECT PLUS Sirolimus-Eluting Coronary Stent System (SECSS) ("CYPHER SELECT PLUS") during commercial use in China.
Detailed Description:
Objectives
* Confirm the safety and effectiveness of the XIENCE V EECSS for the treatment of patients in China
* Evaluate patient compliance with dual antiplatelet therapy (DAPT)
* Evaluate physician-determined XIENCE V EECSS acute performance, deliverability, and resource utilization
Study:
NCT01178268
Study Brief:
Protocol Section:
NCT01178268